MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, XENE has $1,386,810K in assets. $48,991K in debts. $545,867K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
2779.43%
Quick Ratio
2779.43%
Cash Ratio
1371.01%
Debt to Asset Ratio
3.53%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities (note 5)
    • Cash and cash equivalents
    • Marketable securities, long-term...
    • Others
Liabilities Breakdown
    • Common shares, without par value...
    • Accumulated deficit
    • Additional paid-in capital
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
545,867 199,163 104,514 135,381
Marketable securities (note 5)
548,880 349,723 357,754 352,164
Other receivables
1,165 1,371 812 1,097
Prepaid expenses and other current assets
10,720 10,392 17,057 11,610
Total current assets
1,106,632 560,649 480,137 500,252
Marketable securities, long-term (note 4)
244,874 37,152 92,988 137,297
Operating lease right-of-use asset, net (note 5)
6,288 6,626 6,960 7,290
Property, plant and equipment, net
8,294 8,721 8,887 9,205
Deferred tax assets
12,417 12,864 11,750 11,049
Prepaid expenses, long-term
8,305 7,151 7,114 9,188
Total assets
1,386,810 633,163 607,836 674,281
Accounts payable and accrued liabilities (note 6)
38,254 40,260 36,840 31,588
Operating lease liability (note 5)
1,561 1,532 1,495 1,459
Total current liabilities
39,815 41,792 38,335 33,047
Operating lease liability, long-term (note 5)
5,930 6,412 6,832 7,256
Other liabilities, long-term
3,246 3,199 3,158 -
Total liabilities
48,991 51,403 48,325 40,303
Common shares, without par value unlimited shares authorized issued and outstanding 96,624,123 (december 31, 2025 - 80,010,790) (note 7)
2,421,833 1,598,571 1,475,371 1,469,196
Additional paid-in capital
264,879 228,234 223,782 213,892
Accumulated deficit
-1,347,682 -1,245,380 -1,140,119 -1,049,223
Accumulated other comprehensive income (loss)
-1,211 335 477 113
Total shareholders' equity
1,337,819 581,760 559,511 633,978
Total liabilities and shareholders equity
1,386,810 633,163 607,836 674,281
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities(note 5)$548,880K Cash and cashequivalents$545,867K Prepaid expenses andother current assets$10,720K Other receivables$1,165K Total current assets$1,106,632K Marketable securities,long-term (note 4)$244,874K Deferred tax assets$12,417K Prepaid expenses,long-term$8,305K Property, plant andequipment, net$8,294K Operating leaseright-of-use asset, net (note...$6,288K Total assets$1,386,810K Total liabilities andshareholders equity$1,386,810K Total shareholders'equity$1,337,819K Total liabilities$48,991K Accumulated deficit-$1,347,682K Accumulated othercomprehensive income (loss)-$1,211K Common shares, withoutpar value unlimited...$2,421,833K Total currentliabilities$39,815K Operating leaseliability, long-term (note...$5,930K Other liabilities,long-term$3,246K Additional paid-in capital$264,879K Accounts payable andaccrued liabilities...$38,254K Operating lease liability(note 5)$1,561K

logo_icon_teal_2280px-svg

Xenon Pharmaceuticals Inc. (XENE)

logo_icon_teal_2280px-svg

Xenon Pharmaceuticals Inc. (XENE)